share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Rice Derica W

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4:持股變動聲明
SEC announcement ·  04/03 06:46
牛牛AI助理已提取核心訊息
Derica W. Rice, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Rice to the issuer was also not specified. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Derica W. Rice, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Rice to the issuer was also not specified. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
百時美施貴寶(BMY)的舉報人德里卡·賴斯於2024年3月31日參與了該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。賴斯與發行人的關係也沒有具體說明。建議投資者尋求更多信息,以充分了解該事件對其投資決策的影響。
百時美施貴寶(BMY)的舉報人德里卡·賴斯於2024年3月31日參與了該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。賴斯與發行人的關係也沒有具體說明。建議投資者尋求更多信息,以充分了解該事件對其投資決策的影響。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。